Increased thymidylate synthase gene expression in metastatic melanoma

Oncology (Switzerland)

Volumn 54, Issue 2, 1997, Pages 146-152

  Vlaykova, Tatyana ^a   Jekunen, Antti P ^b   Kesomaa, Mika ^b   Kairemo, K J A ^b   Pyrhönen, Seppo ^b   Wasenius, Veli Matti ^b  

^a Trakia University Medical College   (Bulgaria)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gene expression; Metastatic melanoma; Thymidylate synthase

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ACTIN; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MELANOMA; MUSCLE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SPLEEN; THYROID GLAND;

ADULT; AGED; DNA PROBES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MIDDLE AGED; PLOIDIES; POLYMERASE CHAIN REACTION; S PHASE; SKIN NEOPLASMS; THYMIDYLATE SYNTHASE; UP-REGULATION;

EID: 0031047535     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227679     Document Type: Article

References (19)

1. Pyrhönen S, Hahka-Kemppincn M, Millionen T: A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma, J Clin Oncol 1992;10:1919-1926.
2. Crcagan ET, Ahmann DL, Frytak S, Long HJ, Itri LM: Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma: Analysis of complete and long-term responding patients, Cancer 1986;58:2576-2578.
3. Mittelman A, Krown DE, Cirrincione C, Safai B, Octtgcn HF, Koziner B: Analysis of T cell subsets in cancer patients treated with interferon, Am J Med 1983;75:966-972.
4. Ash J, Ke Y, Korb M, Johnson LF: lntrons arc essential for growth-regulated expression of the mouse thymidylate synthase gene, Mol Cell Biol 1993;13:1565-1571.
5. Kancda S, Nalbantoglu J, Takeishi K, Shimizu K, Gotoh O, Seno T, Ayusawa D: Structural and functional analysis of the human thymidylate synthase gene, J Biol Chcm I990;265: 20277-20284.
6. Balch CM, Soong SJ, Shaw HM: An analysis of prognostic factors in 4.000 patients with cutaneous melanoma: in Balch CM, Milton GW (eds): Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide, Philadelphia, Lippincott, 1985, vol 1, p 321.
7. Karlsson M, Jungnelius U, Aamdal S, Boervd B, Carstenscn J, Kâgedal B, Westberg R, Wingren S: Correlation of DNA ploidy and S-phasc fraction with chcniothcrapeutic response and survival in a randomized study of disseminated malignant melanoma, Int J Cancer 1996; 65:1-5.
8. Muhonen T, Pyrhônen S, Laasoncn A, Asko-Seljavaara S, Franssila K: DNA aneuploidy and low S-phasc fraction as favourable prognostic signs in metastatic melanoma, Br J Cancer 1991;64:749-752.
9. Karlsson M, Bocryd B, Carstenscn J, Kâgedal B, Tcrnesten Bratcl A, Wingren S: DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease, Br J Cancer 1993;67:134-138.
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocya-nate-phenol-chloroform extraction, Anal Bio-chcm 1987;162:156-159.
11. Ng SY, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L: Evolution of the functional human beta-actin gene and its multi-pseudo-gene family: Conservation of noncoding regions and chromosomal dispersion of pseudo-genes, Mol Cell Biol 1985;5:2720-2732.
12. Horikoshi T, Danenberg KD, Stadlbauer TH, Volkcnandt M, Sheal C, Aigncr K, Gustavsson B, Lcichman L, Frosing R, Ray M, Gibson NW, Spears CP, Danenberg PV: Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction, Cancer Res 1992:52:108-116.
13. Takeishi K, Kancda S, Ayusawa D, Shimizu K, Gotoh O, Seno T: Nucleotide sequence of a functional cDNA for human thymidylate synthase, Nucleic Acids Res 1985;13:2035-2043.
14. Vindclöv LL, Christensen IJ, Nissen NI: Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards, Cytometry 1983:3:328-332.
15. Elledgc RM, Okuvama N, Fitzgerald SD, Fu-gua SA: Evaluation of thymidylate synthase RNA expression by polymerase chain reaction, Mol Cell Probes 1994;8:67-72.
16. Volm M, Mattem J: Elevated expression of thymidylate synthase in doxorubicin resistant human non-small-cell lung carcinomas, Anti-canccrRes 1992;12:2293-2296.
17. Chu E, Kocller DM, Johnston PG, Zinn S, Alle-gra CJ: Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluor-ouracil and interferon-gamma, Mol Pharmacol 1993;43:527-533.
18. Berger SH, Jenh CH, Johnson LF, Berger FG: Thymidylate synthase overproduction and gene amplification in fluorodcoxyuridine-rcsis-tant human cells, Mol Pharmacol 1985;28: 461-467.
19. Sanguedolcc R, Brumarcscu I, Dardanoni G, Grassadonia A, Vultaggio G, Rausa L: Thymi-dylatc synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: A preliminary study, Anticanccr Res 1995:15:901-906.